My treatment approach to management of the pregnant patient with inflammatory bowel disease

Susie W Ng; Uma Mahadevan

doi:10.1016/j.mayocp.2013.11.012

My treatment approach to management of the pregnant patient with inflammatory bowel disease

Mayo Clin Proc. 2014 Mar;89(3):355-60. doi: 10.1016/j.mayocp.2013.11.012.

Authors

Susie W Ng¹, Uma Mahadevan²

Affiliations

¹ Department of Medicine, Division of Gastroenterology, University of California, San Francisco.
² Department of Medicine, Division of Gastroenterology, University of California, San Francisco. Electronic address: uma.mahadevan@ucsf.edu.

PMID: 24582194
DOI: 10.1016/j.mayocp.2013.11.012

Abstract

Inflammatory bowel disease (IBD) is frequently diagnosed in women of childbearing age. Of paramount concern are questions about the effect of the disease on a woman's ability to conceive and carry the pregnancy safely to term, as well as the effect of the disease and its therapies on the health of the fetus. For health care providers, there is also the issue of medication dose adjustments and management of flares during pregnancy. Growing experience with IBD in pregnancy suggests that most women will have good outcomes; however, concerns and uncertainty remain for both the patient and the physician. This article outlines our approach to the treatment of these patients with respect to preconception counseling and management during pregnancy and the postpartum period.

Publication types

Review

MeSH terms

Anti-Inflammatory Agents / therapeutic use*
Directive Counseling
Female
Humans
Immunosuppressive Agents / therapeutic use*
Inflammatory Bowel Diseases / drug therapy*
Postnatal Care
Preconception Care
Pregnancy
Pregnancy Complications / drug therapy*
Prenatal Care

Substances

Anti-Inflammatory Agents
Immunosuppressive Agents